Current Medical Research and Opinion, Volume 25, Issue 4 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Current Medical Research and Opinion, Volume 25, Issue 4 (2009)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Vol 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Vol 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Volume 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Original Article

Article
In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type
Samuel O. Akapo, June Gupta, Eloisa Martinez & Mark Roach
Pages: 807-816
Published online: 11 Feb 2009
AbstractforIn vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type | Full Text | References | PDF (312.6 KB)
  • 194 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Review Article
2009 update in prevention, evaluation, and outpatient treatment of influenza
James M. Williams
Pages: 817-828
Published online: 11 Feb 2009
Abstractfor2009 update in prevention, evaluation, and outpatient treatment of influenza | Full Text | References | PDF (123.3 KB)
  • 177 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Article

Article
The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis
Stuart Silverman, Ellen M. Dukes, Stephen S. Johnston, Nancy A. Brandenburg, Alesia Sadosky & Dan M. Huse
Pages: 829-840
Published online: 17 Feb 2009
AbstractforThe economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis | Full Text | References | PDF (109.6 KB)
  • 651 Views
  • 82 CrossRef citations
  • 0Altmetric

Review

Review Article
Levodopa-related wearing-off in Parkinson's disease: identification and management
Rajesh Pahwa & Kelly E. Lyons
Pages: 841-849
Published online: 19 Feb 2009
AbstractforLevodopa-related wearing-off in Parkinson's disease: identification and management | Full Text | References | PDF (98.3 KB)
  • 1870 Views
  • 64 CrossRef citations
  • 0Altmetric

Original Article

Article
First-year treatment patterns among new initiators of topical prostaglandin analogs
Jordana K. Schmier, David W. Covert & Alan L. Robin
Pages: 851-858
Published online: 20 Feb 2009
AbstractforFirst-year treatment patterns among new initiators of topical prostaglandin analogs | Full Text | References | PDF (118.3 KB)
  • 125 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study
C. R. Frei, T. C. Jaso, E. M. Mortensen, M. I. Restrepo, M. K. Raut, C. U. Oramasionwu, A. D. Ruiz, B. R. Makos, J. L. Ruiz, R. T. Attridge, S. H. Mody, A. Fisher & J. R. Schein
Pages: 859-868
Published online: 20 Feb 2009
AbstractforMedical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study | Full Text | References | PDF (131.5 KB)
  • 405 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs
Howard G. Birnbaum, Jasmina I. Ivanova, Seth Samuels, Matthew Davis, Pierre Y. Cremieux, Amy L. Phillips & Dennis Meletiche
Pages: 869-877
Published online: 23 Feb 2009
AbstractforEconomic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs | Full Text | References | PDF (96.7 KB)
  • 439 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment
H. Völler, R. Reibis, D. Pittrow, C. Jannowitz, K. Wegscheider, B. Karmann & K. Bestehorn
Pages: 879-890
Published online: 03 Mar 2009
AbstractforSecondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment | Full Text | References | PDF (132.6 KB)
  • 253 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates
Michael Derks, Stephen Fowler & Olaf Kuhlmann
Pages: 891-902
Published online: 26 Feb 2009
AbstractforIn vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates | Full Text | References | PDF (134.6 KB)
  • 324 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone
Matthias Blumenstein, Jerzy Romaszko, Alberto Calderón, Karl Andersen, Ghionul Ibram, Zhaohui Liu & Jack Zhang
Pages: 903-910
Published online: 26 Feb 2009
AbstractforAntihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone | Full Text | References | PDF (291.5 KB)
  • 121 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
Miriam G. Cisternas, Aimee J. Foreman, Thomas S. Marshall, M. Chris Runken, Kathleen C. Kobashi & Raafat Seifeldin
Pages: 911-919
Published online: 27 Feb 2009
AbstractforEstimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage | Full Text | References | PDF (104.8 KB)
  • 196 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment
Sven Prevrhal, John H. Krege, Peiqi Chen, Harry Genant & Dennis M. Black
Pages: 921-928
Published online: 27 Feb 2009
AbstractforTeriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment | Full Text | References | PDF (127.1 KB)
  • 1034 Views
  • 49 CrossRef citations
  • 0Altmetric

Review

Review Article
Optimal recall periods for patient-reported outcomes: challenges and potential solutions
Donald E. Stull, Nancy Kline Leidy, Bhash Parasuraman & Olivier Chassany
Pages: 929-942
Published online: 27 Feb 2009
AbstractforOptimal recall periods for patient-reported outcomes: challenges and potential solutions | Full Text | References | PDF (146 KB)
  • 2321 Views
  • 249 CrossRef citations
  • 0Altmetric

Original Article

Article
Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries
Bin Zhang, David L Hepner, Mary Helen Tran, Mark Friedman, Jonathan R. Korn & Joseph Menzin
Pages: 943-950
Published online: 02 Mar 2009
AbstractforNeuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries | Full Text | References | PDF (96.4 KB)
  • 362 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
Thomas W. Littlejohn III, Peter Trenkwalder, Geert Hollanders, Yanxing Zhao & Weichi Liao
Pages: 951-959
Published online: 02 Mar 2009
AbstractforLong-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension | Full Text | References | PDF (204.5 KB)
  • 277 Views
  • 48 CrossRef citations
  • 0Altmetric
Article
Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study
Thomas Rath, Robert A. Mactier, Thomas Weinreich, Armin W. Scherhag, on behalf of the GAIN investigators & on behalf of the GAIN investigators
Pages: 961-970
Published online: 03 Mar 2009
AbstractforEffectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study | Full Text | References | PDF (135.5 KB)
  • 460 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study
V. G. Athyros, A. Karagiannis, A. I. Hatzitolios, K. Paletas, C. Savopoulos, G. Giannoglou, D. P. Mikhailidis, on behalf of the SAGE-METS collaborative group* & on behalf of the SAGE-METS collaborative group
Pages: 971-980
Published online: 04 Mar 2009
AbstractforStandardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study | Full Text | References | PDF (119.6 KB)
  • 228 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of losartan 100 mg or losartan 100 mg plus hydrochlorothiazide 25 mg in the treatment of patients with essential arterial hypertension and CV risk factors: obser-vational, prospective study in primary care
G. Bönner, W. Smolka, C. Jung & K. Bestehorn
Pages: 981-990
Published online: 03 Mar 2009
AbstractforEfficacy and safety of losartan 100 mg or losartan 100 mg plus hydrochlorothiazide 25 mg in the treatment of patients with essential arterial hypertension and CV risk factors: obser-vational, prospective study in primary care | Full Text | References | PDF (116.9 KB)
  • 388 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review Article
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
Vinod K. Rustgi
Pages: 991-1002
Published online: 11 Mar 2009
AbstractforAlbinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C | Full Text | References | PDF (505.6 KB)
  • 285 Views
  • 35 CrossRef citations
  • 0Altmetric

Original Article

Article
Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany
Ulrich Thelen, Patricia Buchholz & Friedemann Kimmich
Pages: 1003-1009
Published online: 11 Mar 2009
AbstractforTreatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany | Full Text | References | PDF (473.6 KB)
  • 98 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β2-adrenergic polymorphisms
Steven W. Yancey, Michael Klotsman, Hector G. Ortega, Lisa D. Edwards & Wayne H. Anderson
Pages: 1011-1018
Published online: 11 Mar 2009
AbstractforAcute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β2-adrenergic polymorphisms | Full Text | References | PDF (125.7 KB)
  • 109 Views
  • 6 CrossRef citations
  • 0Altmetric

Brief Report

Brief Report
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
David D. Dore, John D. Seeger & K. Arnold Chan
Pages: 1019-1027
Published online: 12 Mar 2009
AbstractforUse of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide | Full Text | References | PDF (94.8 KB)
  • 1507 Views
  • 259 CrossRef citations
  • 0Altmetric

Original Article

Article
Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study
L. F. Meneghini, A. Dornhorst, S. Sreenan, on behalf of the PREDICTIVE Study Group & on behalf of the PREDICTIVE Study Group
Pages: 1029-1035
Published online: 13 Mar 2009
AbstractforOnce-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study | Full Text | References | PDF (265.8 KB)
  • 293 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study
Cord Feuerhake, Patricia Buchholz & Friedemann Kimmich
Pages: 1037-1043
Published online: 16 Mar 2009
AbstractforEfficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study | Full Text | References | PDF (562.5 KB)
  • 131 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles